Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
01 1Polfa Tarchomin
02 1Antibiotice SA
03 3Ascent Innovative Medicines
04 38Associated Biotech
05 7Atabay Group of Companies
06 3Avva Rus JSC
07 17Brooks laboratories Limited
08 1DEVATS INDIA
09 6DEVATS INDIA PRIVATE LTD
10 2Darou Pakhsh Pharma Chem Co
11 2Dr Seidel Life Science
12 1Embiotic Laboratories
13 1Flagship Biotech International Pvt. Ltd
14 3Hanlim Pharmaceutical
15 5Health Biotech
16 2IBN Savio
17 1InterMed
18 1KRUX Pharma
19 1Leeford Healthcare
20 23Medicef Pharma
21 2Myungmoon Pharm. Co., LTD.
22 7Neopharma
23 11Nishchem International Pvt. Ltd
24 1Orofino Pharmaceuticals Group
25 2RELIANCE FORMULATION PVT. LTD
26 2Smith & Kenner Pharmaceuticals
27 1Symbiosis Pharma
28 10Themis Medicare
29 4Unichem Laboratories Limited
30 1Vaishali Pharma Ltd
31 2World Medicine
32 2ZRS LABS
33 11Blank
01 1Amoxicillin Anhydrous; Clavulanic Acid
02 2Amoxicillin Sodium; Clavulanic Acid
03 2Amoxicillin Trihydrate; Clavulanate Potassium
04 81Amoxicillin Trihydrate; Clavulanic Acid
05 1Amoxicillin; CLAVULANIC ACID POTASSIUM
06 14Amoxicillin; Clavulanate Potassium
07 35Amoxicillin; Clavulanic Acid
08 1Amoxycillin Trihydrate; Potassium Clavulanate
09 3Amoxycillin; Clavulanic Acid
10 2Cefixime; Clavulanate Potassium
11 6Cefixime; Clavulanic Acid
12 6Cefpodoxime Proxetil; Clavulanate Potassium
13 5Cefpodoxime Proxetil; Clavulanic Acid
14 1Cefpodoxime; Clavulanic Acid
15 8Cefuroxime Axetil; Clavulanic Acid
16 4Clavulanic Acid
17 3Ticarcillin; Clavulanic Acid
01 8Dispersible Tablet
02 2Drops
03 5Dry Powder Injectable
04 6Dry Syrup
05 1ER Tablet
06 5FC Tablet
07 2FILM COATED TABLET
08 11Film Coated Tablet
09 1Film Tablet
10 1Film-coated Tablet; Film-coated Tablet
11 1FilmTablet
12 6Injection
13 10OS
14 8Oral Suspension
15 2POWDER
16 1Pediatric Powder for Oral Suspension
17 4Powder for Oral Solution
18 7Powder for Oral Suspension
19 1Reconstituted syrup
20 1SYRUP
21 12Sachet
22 20Suspension
23 4TABLET
24 53Tablet
25 1Tablets
26 1Vial
27 1powder for injection/Infusion
01 11.2GM; 1.2GM
02 11.7GM; 10ML
03 21000MG
04 41000MG; 125MG
05 21000MG; 200MG
06 21000MG; 62.5MG
07 2100MG; 12.5MG
08 4100MG; 62.5MG
09 21125MG
10 1125MG
11 1125MG/5ML; 31.25MG/5ML
12 2125MG; 31.25MG
13 1125MG; 31.5MG
14 1150MG; 150MG
15 1156.25MG
16 21:1
17 1200MG/5ML; 28.5MG/5ML
18 8200MG; 125MG
19 8200MG; 28.5MG
20 1228.5MG
21 1228.5MG; 5ML
22 1250MG
23 1250MG/5ML; 62.5MG/5ML
24 10250MG; 125MG
25 3250MG; 31.25MG
26 1250MG; 31.5MG
27 4250MG; 62.5MG
28 128.5MG/5ML
29 13.1GM; 3.1GM
30 13.7G/30ML
31 1300MG; 300MG
32 1312.5MG
33 1375MG
34 13G; 100MG
35 1400MG/5ML; 57MG/5ML
36 9400MG; 57MG
37 140MG/ML; 5.7MG/ML
38 1437.5MG; 62.5MG
39 14500MG
40 1457MG
41 1500 MG ; 125 MG
42 1500MG
43 20500MG; 125MG
44 6500MG; 62.5MG
45 250MG; 12.5MG
46 250MG; 31.25MG
47 2562.5MG
48 1600MG/5ML; 42.9MG/5ML
49 2600MG; 42.9MG
50 1600MG; 600MG
51 1625MG
52 1800MG; 57MG
53 280MG; 11.4MG
54 18875MG; 125MG
55 26Blank
01 2Germany
02 142India
03 2Iran
04 3Italy
05 1Poland
06 1Romania
07 3Russia
08 5South Korea
09 9Turkey
10 7U.A.E
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Amoxicillin Trihydrate; Clavulanic Acid
Brand Name :
Dosage Form : Powder for Oral Suspen...
Dosage Strength : 600MG; 42.9MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q3 2024
Registration Country : Poland
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Packaging :
Regulatory Info : Dossier Availability: Q3 2024
Amoxicillin Trihydrate; Clavulanic Acid
Dosage : Powder for Oral Suspen...
Dosage Strength : 600MG; 42.9MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Poland
Regulatory Info : Generic
Registration Country : Iran
Brand Name :
Dosage Form : POWDER
Dosage Strength : 1:1
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Iran
Packaging :
Regulatory Info : Generic
Dosage : POWDER
Dosage Strength : 1:1
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran
Regulatory Info : Generic
Registration Country : Iran
Brand Name :
Dosage Form : POWDER
Dosage Strength : 1:1
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Iran
Packaging :
Regulatory Info : Generic
Dosage : POWDER
Dosage Strength : 1:1
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Dosage : Injection
Dosage Strength :
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NEWCLA
Dosage Form : TABLET
Dosage Strength : 250MG; 125MG
Packaging : 80T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 80T
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 250MG; 125MG
Brand Name : NEWCLA
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NEWCLA
Dosage Form : TABLET
Dosage Strength : 500MG; 125MG
Packaging : 40T
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 40T
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 500MG; 125MG
Brand Name : NEWCLA
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic
Registration Country : South Korea
Brand Name : NEWCLA
Dosage Form : SYRUP
Dosage Strength : 40MG/ML; 5.7MG/ML
Packaging : 50ml,10BTL
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Korea
Packaging : 50ml,10BTL
Regulatory Info : Generic
Dosage : SYRUP
Dosage Strength : 40MG/ML; 5.7MG/ML
Brand Name : NEWCLA
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic B.E study
Registration Country : South Korea
Brand Name : Amoclan Duo
Dosage Form : TABLET
Dosage Strength : 437.5MG; 62.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic B.E study
Registration Country : South Korea
Packaging :
Regulatory Info : Generic B.E study
Dosage : TABLET
Dosage Strength : 437.5MG; 62.5MG
Brand Name : Amoclan Duo
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic B.E study
Registration Country : South Korea
Brand Name : Amoclan
Dosage Form : TABLET
Dosage Strength : 250MG; 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic B.E study
Registration Country : South Korea
Packaging :
Regulatory Info : Generic B.E study
Dosage : TABLET
Dosage Strength : 250MG; 125MG
Brand Name : Amoclan
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info : Generic ACTD Dossier- Available
Registration Country : India
Brand Name :
Dosage Form : Suspension
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic ACTD Dossier- Available
Registration Country : India
Packaging :
Regulatory Info : Generic ACTD Dossier- Available
Dosage : Suspension
Dosage Strength :
Brand Name :
Approval Date :
Application Number :
Registration Country : India
